000 | 02027namaa2200385uu 4500 | ||
---|---|---|---|
001 | oapen32326 | ||
003 | oapen | ||
005 | 20240507100117.0 | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 161231s2012 xx |||||o ||| 0|eng d | ||
020 | _a2689 | ||
020 | _a9809533075827 | ||
024 | 7 |
_a10.5772/2689 _2doi |
|
040 |
_aoapen _coapen |
||
041 | 0 | _aeng | |
042 | _adc | ||
072 | 7 |
_aPD _2bicssc |
|
100 | 1 |
_aTyshenko, Michael G. _4edt |
|
245 | 1 | 0 | _aThe Continuum of Health Risk Assessments |
260 |
_bInTechOpen _c2012 |
||
300 | _a1 online resource (208 p.) | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
506 | 0 |
_aFree-to-read _fUnrestricted online access _2star |
|
520 | _aThis book presents a collection of health risk assessments for known and emerging hazards that span a continuum. Case studies for existing health risks include psychoactive drug usage in delivery truck drivers and using look-back risk assessment for accidental syringe re-use in healthcare settings. Case studies for emerging risks include precautionary actions to safeguard blood supplies; nanoparticle deposition in the lung; and the epistemic issues surrounding genetically modified organism risk assessments. The final section of the book deals with advancing health risk assessment analyses through a post-genomics lens and provides case studies on personalized genomics, new data analyses and improving in silico models for risk assessment. These case studies provide much insight into the ongoing evolution of health risk assessments. | ||
540 |
_aAll rights reserved _uhttp://oapen.org/content/about-rights |
||
546 | _aEnglish | ||
650 | 7 |
_aScience: general issues _2bicssc |
|
653 | _ahealth risk assessments | ||
700 | 1 |
_aTyshenko, Michael G. _4oth |
|
793 | 0 | _aOAPEN Library. | |
856 | 4 | 0 |
_uhttp://library.oapen.org/handle/20.500.12657/32326 _70 _zFree-to-read: OAPEN Library: description of the publication |
999 |
_c36312 _d36312 |